AlzeCure gets two NeuroRestore abstracts accepted to Alzheim

AlzeCure Pharma AB , a pharmaceutical company that develops a broad portfolio of small molecule candidate drugs for diseases affecting the central nervous system, with projects in both... | March 22, 2022

Related Keywords

Sweden , Swedish , Pontus Forsell , Cristina Parrado Fern , Johan Sandin , Neurotrophin Trk , Alzheimer Research , Results From , Single Ascending Dose Study , Positive Modulator , Neurotrophin Trk Receptors , Swedish Meeting , Alzecure Pharma Ab Publ Stock Exchange , News , Information , Press Release , Alzecure , Dharma , Tb , Harmaceutical , Company , Hat , Evelops , Road , Portfolio , F , Mall , Olecule , Candidate , Drugs , Or , Diseases , Effecting , The , Central , Nervous , Ith , Projects , N Alzcur Se0010133785 ,